Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors

  • Elena M. VazeyEmail author
  • Carolina R. den Hartog
  • David E. Moorman
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 248)


Alcohol use disorder (AUD) results from disruption of a number of neural systems underlying motivation, emotion, and cognition. Patients with AUD exhibit not only elevated motivation for alcohol but heightened stress and anxiety, and disruptions in cognitive domains such as decision-making. One system at the intersection of these functions is the central norepinephrine (NE) system. This catecholaminergic neuromodulator, produced by several brainstem nuclei, plays profound roles in a wide range of behaviors and functions, including arousal, attention, and other aspects of cognition, motivation, emotional regulation, and control over basic physiological processes. It has been known for some time that NE has an impact on alcohol seeking and use, but the mechanisms of its influence are still being revealed. This chapter will discuss the influence of NE neuron activation and NE release at alcohol-relevant targets on behaviors and disruptions underlying alcohol motivation and AUD. Potential NE-based pharmacotherapies for AUD treatment will also be discussed. Given the basic properties of NE function, the strong relationship between NE and alcohol use, and the effectiveness of current NE-related treatments, the studies presented here indicate an encouraging direction for the development of precise and efficacious future therapies for AUD.


Adrenergic receptors Allostasis Dependence Locus coeruleus Nucleus tractus solitarius Reward Withdrawal 



This work was supported by NIH grants AA024571 (EMV/DEM) and AA025481 (DEM).


  1. Aghajanian GK, Cedarbaum JM, Wang RY (1977) Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res 136:570–577PubMedGoogle Scholar
  2. Aimino MA, Coker CR, Silberman Y (2017) Acute ethanol modulation of neurocircuit function in the nucleus of the tractus solitarius. Brain Res Bull.
  3. Alari L, Lewander T, Sjoquist B (1987a) The effect of ethanol on the brain catecholamine systems in female mice, rats, and guinea pigs. Alcohol Clin Exp Res 11:144–149PubMedGoogle Scholar
  4. Alari L, Sjoquist B, Lewander T (1987b) Ethanol-induced hypothermia and biogenic amine metabolites. Drug Alcohol Depend 19:369–373PubMedGoogle Scholar
  5. Amit Z, Brown ZW (1982) Actions of drugs of abuse on brain reward systems: a reconsideration with specific attention to alcohol. Pharmacol Biochem Behav 17:233–238PubMedGoogle Scholar
  6. Amit Z, Brown ZW, Levitan DE, Ogren SO (1977) Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition. Arch Int Pharmacodyn Ther 230:65–75PubMedGoogle Scholar
  7. Andreas K, Fischer HD, Schmidt J (1983) Effect of central effective substances on alcohol preference. Biomed Biochim Acta 42:391–398PubMedGoogle Scholar
  8. Aoki C, Go CG, Venkatesan C, Kurose H (1994) Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. Brain Res 650:181–204PubMedGoogle Scholar
  9. Aoki C, Venkatesan C, Go CG, Forman R, Kurose H (1998) Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons. Cereb Cortex 8:269–277PubMedGoogle Scholar
  10. Asan E (1998) The catecholaminergic innervation of the rat amygdala. Adv Anat Embryol Cell Biol 142:1–118PubMedGoogle Scholar
  11. Aston-Jones G, Bloom FE (1981) Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci 1:887–900PubMedGoogle Scholar
  12. Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28:403–450PubMedGoogle Scholar
  13. Aston-Jones G, Foote SL, Bloom FE (1982) Low doses of ethanol disrupt sensory responses of brain noradrenergic neurones. Nature 296:857–860PubMedGoogle Scholar
  14. Aston-Jones G, Zhu Y, Card JP (2004) Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. J Neurosci 24:2313–2321PubMedGoogle Scholar
  15. Baker KG, Tork I, Hornung JP, Halasz P (1989) The human locus coeruleus complex: an immunohistochemical and three dimensional reconstruction study. Exp Brain Res 77:257–270PubMedGoogle Scholar
  16. Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H, Van Bockstaele EJ, Valentino RJ (2010) Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15(877):896–904Google Scholar
  17. Barson JR, Leibowitz SF (2016) Hypothalamic neuropeptide signaling in alcohol addiction. Prog Neuro-Psychopharmacol Biol Psychiatry 65:321–329Google Scholar
  18. Becker HC (2012) Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption. Alcohol Res 34:448–458PubMedPubMedCentralGoogle Scholar
  19. Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33–84PubMedGoogle Scholar
  20. Berridge CW, Stratford TL, Foote SL, Kelley AE (1997) Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 27:230–241PubMedGoogle Scholar
  21. Bevan P, Bradshaw CM, Roberts MH, Szabadi E (1973) The excitation of neurons by noradrenaline. J Pharm Pharmacol 25:309–314PubMedGoogle Scholar
  22. Borg S, Kvande H, Sedvall G (1981) Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science 213:1135–1137PubMedGoogle Scholar
  23. Brown ZW, Amit Z (1977) The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats. Neurosci Lett 5(6):333PubMedGoogle Scholar
  24. Brown ZW, Amit Z, Levitan DE, Ogren SO, Sutherland EA (1977) Noradrenergic mediation of the positive reinforcing properties of ethanol: II. Extinction of ethanol-drinking behavior in laboratory rats by inhibition of dopamine-beta-hydroxylase. Implications for treatment procedures in human alcoholics. Arch Int Pharmacodyn Ther 230:76–82PubMedGoogle Scholar
  25. Carlsson C (1976) Propranolol in the treatment of alchoholism: a review. Postgrad Med J 52(Suppl 4):166–167PubMedGoogle Scholar
  26. Cedarbaum JM, Aghajanian GK (1978) Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J Comp Neurol 178(1):16Google Scholar
  27. Chang HT (1989) Noradrenergic innervation of the substantia innominata: a light and electron microscopic analysis of dopamine beta-hydroxylase immunoreactive elements in the rat. Exp Neurol 104:101–112PubMedGoogle Scholar
  28. Chang SL, Patel NA, Romero AA (1995) Activation and desensitization of Fos immunoreactivity in the rat brain following ethanol administration. Brain Res 679:89–98PubMedGoogle Scholar
  29. Clarke TK, Dempster E, Docherty SJ, Desrivieres S, Lourdsamy A, Wodarz N, Ridinger M, Maier W, Rietschel M, Schumann G (2012) Multiple polymorphisms in genes of the adrenergic stress system confer vulnerability to alcohol abuse. Addict Biol 17:202–208PubMedGoogle Scholar
  30. Clayton EC, Rajkowski J, Cohen JD, Aston-Jones G (2004) Phasic activation of monkey locus ceruleus neurons by simple decisions in a forced-choice task. J Neurosci 24:9914–9920PubMedGoogle Scholar
  31. Corcoran ME, Lewis J, Fibiger HC (1983) Forebrain noradrenaline and oral self-administration of ethanol by rats. Behav Brain Res 8:1–21PubMedGoogle Scholar
  32. Corrodi H, Fuxe K, Hokfelt T (1966) The effect of ethanol on the activity of central catecholamine neurones in rat brain. J Pharm Pharmacol 18:821–823PubMedGoogle Scholar
  33. Cui C, Noronha A, Warren KR, Koob GF, Sinha R, Thakkar M, Matochik J, Crews FT, Chandler LJ, Pfefferbaum A, Becker HC, Lovinger D, Everitt BJ, Egli M, Mandyam CD, Fein G, Potenza MN, Harris RA, Grant KA, Roberto M, Meyerhoff DJ, Sullivan EV (2015) Brain pathways to recovery from alcohol dependence. Alcohol 49:435–452PubMedPubMedCentralGoogle Scholar
  34. Dahlstrom A, Fuxe K (1964) Localization of monoamines in the lower brain stem. Experientia 20:398–399PubMedGoogle Scholar
  35. Daniel SE, Rainnie DG (2016) Stress modulation of opposing circuits in the bed nucleus of the Stria terminalis. Neuropsychopharmacology 41:103–125PubMedGoogle Scholar
  36. Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS (1998) Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 806:127–140PubMedGoogle Scholar
  37. Do Monte FH, Canteras NS, Fernandes D, Assreuy J, Carobrez AP (2008) New perspectives on beta-adrenergic mediation of innate and learned fear responses to predator odor. J Neurosci 28:13296–13302PubMedGoogle Scholar
  38. Domyancic AV, Morilak DA (1997) Distribution of alpha1A adrenergic receptor mRNA in the rat brain visualized by in situ hybridization. J Comp Neurol 386:358–378PubMedGoogle Scholar
  39. Dragunow M, Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261–265PubMedGoogle Scholar
  40. Ennis M, Aston-Jones G (1988) Activation of locus coeruleus from nucleus paragigantocellularis: a new excitatory amino acid pathway in brain. J Neurosci 8:3644–3657PubMedGoogle Scholar
  41. Espana RA, Schmeichel BE, Berridge CW (2016) Norepinephrine at the nexus of arousal, motivation and relapse. Brain Res 1641:207–216PubMedPubMedCentralGoogle Scholar
  42. Fitzgerald PJ (2013) Elevated norepinephrine may be a unifying etiological factor in the abuse of a broad range of substances: alcohol, nicotine, marijuana, heroin, cocaine, and caffeine. Subst Abuse 7:171–183PubMedPubMedCentralGoogle Scholar
  43. Foote SL, Freedman R, Oliver AP (1975) Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res 86:229–242PubMedGoogle Scholar
  44. Fox HC, Anderson GM, Tuit K, Hansen J, Kimmerling A, Siedlarz KM, Morgan PT, Sinha R (2012) Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. Alcohol Clin Exp Res 36:351–360PubMedGoogle Scholar
  45. Fredriksson I, Jayaram-Lindstrom N, Wirf M, Nylander E, Nystrom E, Jardemark K, Steensland P (2015) Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings. Neuropsychopharmacology 40:1130–1140PubMedGoogle Scholar
  46. Froehlich JC, Hausauer BJ, Federoff DL, Fischer SM, Rasmussen DD (2013) Prazosin reduces alcohol drinking throughout prolonged treatment and blocks the initiation of drinking in rats selectively bred for high alcohol intake. Alcohol Clin Exp Res 37:1552–1560PubMedPubMedCentralGoogle Scholar
  47. Froehlich JC, Hausauer B, Fischer S, Wise B, Rasmussen DD (2015) Prazosin reduces alcohol intake in an animal model of alcohol relapse. Alcohol Clin Exp Res 39:1538–1546PubMedPubMedCentralGoogle Scholar
  48. Funk D, Coen K, Tamadon S, Li Z, Loughlin A, Le AD (2016) Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in rats. Psychopharmacology 233:2197–2207PubMedGoogle Scholar
  49. Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. 3. The monoamine nerve terminal. Z Zellforsch Mikrosk Anat 65:573–596PubMedGoogle Scholar
  50. Gilpin NW (2012) Corticotropin-releasing factor (CRF) and neuropeptide Y (NPY): effects on inhibitory transmission in central amygdala, and anxiety- & alcohol-related behaviors. Alcohol 46:329–337PubMedPubMedCentralGoogle Scholar
  51. Gilpin NW, Koob GF (2010) Effects of beta-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats. Psychopharmacology 212:431–439PubMedPubMedCentralGoogle Scholar
  52. Gilpin NW, Roberto M (2012) Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. Neurosci Biobehav Rev 36:873–888PubMedGoogle Scholar
  53. Giustino TF, Fitzgerald PJ, Maren S (2016) Revisiting propranolol and PTSD: memory erasure or extinction enhancement? Neurobiol Learn Mem 130:26–33PubMedPubMedCentralGoogle Scholar
  54. Gorman AL, Dunn AJ (1993) Beta-adrenergic receptors are involved in stress-related behavioral changes. Pharmacol Biochem Behav 45:1–7PubMedGoogle Scholar
  55. Hawley RJ, Nemeroff CB, Bissette G, Guidotti A, Rawlings R, Linnoila M (1994) Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcohol Clin Exp Res 18(6):1312PubMedGoogle Scholar
  56. Herman JP (2017) Regulation of hypothalamo-pituitary-adrenocortical responses to stressors by the nucleus of the solitary tract/dorsal vagal complex. Cell Mol Neurobiol 38(1):25–35PubMedPubMedCentralGoogle Scholar
  57. Howes LG, Reid JL (1985) Changes in plasma free 3,4-dihydroxyphenylethylene glycol and noradrenaline levels after acute alcohol administration. Clin Sci (Lond) 69:423–428Google Scholar
  58. Jones BE, Moore RY (1977) Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 127:25–53PubMedGoogle Scholar
  59. Kalwani RM, Joshi S, Gold JI (2014) Phasic activation of individual neurons in the locus ceruleus/subceruleus complex of monkeys reflects rewarded decisions to go but not stop. J Neurosci 34:13656–13669PubMedPubMedCentralGoogle Scholar
  60. Karkhanis AN, Locke JL, McCool BA, Weiner JL, Jones SR (2014) Social isolation rearing increases nucleus accumbens dopamine and norepinephrine responses to acute ethanol in adulthood. Alcohol Clin Exp Res 38:2770–2779PubMedPubMedCentralGoogle Scholar
  61. Karkhanis AN, Alexander NJ, McCool BA, Weiner JL, Jones SR (2015) Chronic social isolation during adolescence augments catecholamine response to acute ethanol in the basolateral amygdala. Synapse 69:385–395PubMedPubMedCentralGoogle Scholar
  62. Karoum F, Wyatt RJ, Majchrowicz E (1976) Brain concentrations of biogenic amine metabolites in acutely treated and ethanol-dependent rats. Br J Pharmacol 56:403–411PubMedPubMedCentralGoogle Scholar
  63. Kiianmaa K, Attila LM (1979) Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment. Naunyn Schmiedeberg’s Arch Pharmacol 308:165–170Google Scholar
  64. Kiianmaa K, Fuxe K, Jonsson G, Ahtee L (1975) Evidence for involvement of central NA neurones in alcohol intake. Increased alcohol consumption after degeneration of the NA pathway to the cortex cerebri. Neurosci Lett 1:41–45Google Scholar
  65. Kim AK, Souza-Formigoni ML (2013) Alpha1-adrenergic drugs affect the development and expression of ethanol-induced behavioral sensitization. Behav Brain Res 256:646–654PubMedGoogle Scholar
  66. Knapp DJ, Duncan GE, Crews FT, Breese GR (1998) Induction of Fos-like proteins and ultrasonic vocalizations during ethanol withdrawal: further evidence for withdrawal-induced anxiety. Alcohol Clin Exp Res 22:481–493PubMedGoogle Scholar
  67. Kolodziejska-Akiyama KM, Cha YM, Jiang Y, Loh HH, Chang SL (2005) Ethanol-induced FOS immunoreactivity in the brain of mu-opioid receptor knockout mice. Drug Alcohol Depend 80:161–168PubMedGoogle Scholar
  68. Koob GF (2014) Neurocircuitry of alcohol addiction: synthesis from animal models. Handb Clin Neurol 125:33–54PubMedGoogle Scholar
  69. Kostowski W, Trzaskowska E (1980) Effects of lesion of the locus coeruleus and clonidine treatment on ethanol withdrawal syndrome in rats. Pol J Pharmacol Pharm 32:617–623PubMedGoogle Scholar
  70. Lanteri C, Salomon L, Torrens Y, Glowinski J, Tassin JP (2008) Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 33:1724–1734PubMedGoogle Scholar
  71. Le AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 179:366–373PubMedGoogle Scholar
  72. Lee S, Craddock Z, Rivier C (2011) Brain stem catecholamines circuitry: activation by alcohol and role in the hypothalamic-pituitary-adrenal response to this drug. J Neuroendocrinol 23:531–541PubMedPubMedCentralGoogle Scholar
  73. Levitt P, Moore RY (1979) Origin and organization of brainstem catecholamine innervation in the rat. J Comp Neurol 186:505–528PubMedGoogle Scholar
  74. Litten RZ, Falk DE, Ryan ML, Fertig J, Leggio L (2018) Advances in pharmacotherapy development: human clinical studies. Handb Exp Pharmacol.
  75. MacDonald E, Kobilka BK, Scheinin M (1997) Gene targeting – homing in on alpha 2-adrenoceptor-subtype function. Trends Pharmacol Sci 18:211–219PubMedGoogle Scholar
  76. McElligott ZA, Klug JR, Nobis WP, Patel S, Grueter BA, Kash TL, Winder DG (2010) Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. Proc Natl Acad Sci U S A 107:2271–2276PubMedPubMedCentralGoogle Scholar
  77. Melander T, Hokfelt T, Rokaeus A, Cuello AC, Oertel WH, Verhofstad A, Goldstein M (1986) Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 6:3640–3654PubMedGoogle Scholar
  78. Moore RY, Bloom FE (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 2:113–168PubMedGoogle Scholar
  79. Morrow AL, Creese I (1986) Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol 29:321–330PubMedGoogle Scholar
  80. Murphy JM, McBride WJ, Lumeng L, Li TK (1983) Monoamine and metabolite levels in CNS regions of the P line of alcohol-preferring rats after acute and chronic ethanol treatment. Pharmacol Biochem Behav 19:849–856PubMedGoogle Scholar
  81. Musini VM, Gueyffier F, Puil L, Salzwedel DM, Wright JM (2017) Pharmacotherapy for hypertension in adults aged 18 to 59 years. Cochrane Database Syst Rev 8:CD008276PubMedGoogle Scholar
  82. Muzyk AJ, Fowler JA, Norwood DK, Chilipko A (2011) Role of alpha2-agonists in the treatment of acute alcohol withdrawal. Ann Pharmacother 45:649–657PubMedGoogle Scholar
  83. Nicholas AP, Pieribone V, Hokfelt T (1993a) Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328:575–594PubMedGoogle Scholar
  84. Nicholas AP, Pieribone VA, Hokfelt T (1993b) Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: an in situ hybridization study. Neuroscience 56:1023–1039PubMedGoogle Scholar
  85. O’Neil ML, Beckwith LE, Kincaid CL, Rasmussen DD (2013) The alpha1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) rats. Alcohol Clin Exp Res 37:202–212PubMedGoogle Scholar
  86. Olpe HR, Steinmann M (1991) Responses of locus coeruleus neurons to neuropeptides. Prog Brain Res 88:241–248PubMedGoogle Scholar
  87. Opitz K (1990) The effect of clonidine and related substances on voluntary ethanol consumption in rats. Drug Alcohol Depend 25:43–48PubMedGoogle Scholar
  88. Osmanovic SS, Shefner SA (1994) Ethanol enhances inward rectification in rat locus ceruleus neurons by increasing the extracellular potassium concentration. J Pharmacol Exp Ther 271:334–342PubMedGoogle Scholar
  89. Park J, Kile BM, Wightman RM (2009) In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus. Eur J Neurosci 30:2121–2133PubMedPubMedCentralGoogle Scholar
  90. Petrakis IL, Trevisan L, D’Souza C, Gil R, Krasnicki S, Webb E, Heninger G, Cooney N, Krystal JH (1999) CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving? Alcohol Clin Exp Res 23:1336–1341PubMedGoogle Scholar
  91. Phelix CF, Liposits Z, Paull WK (1992) Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res Bull 28:949–965PubMedGoogle Scholar
  92. Putzke J, Spanagel R, Tolle TR, Zieglgansberger W (1996) The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. Eur J Pharmacol 317:39–48PubMedGoogle Scholar
  93. Ramos BP, Arnsten AF (2007) Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther 113:523–536PubMedGoogle Scholar
  94. Rasmussen DD, Wilkinson CW, Raskind MA (2006) Chronic daily ethanol and withdrawal: 6. Effects on rat sympathoadrenal activity during “abstinence”. Alcohol 38:173–177PubMedPubMedCentralGoogle Scholar
  95. Rasmussen DD, Alexander L, Malone J, Federoff D, Froehlich JC (2014a) The alpha2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats. Alcohol 48:543–549PubMedPubMedCentralGoogle Scholar
  96. Rasmussen DD, Beckwith LE, Kincaid CL, Froehlich JC (2014b) Combining the alpha1-adrenergic receptor antagonist, prazosin, with the beta-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone. Alcohol Clin Exp Res 38:1532–1539PubMedPubMedCentralGoogle Scholar
  97. Rasmussen DD, Kincaid CL, Froehlich JC (2017) Prazosin prevents increased anxiety behavior that occurs in response to stress during alcohol deprivations. Alcohol Alcohol 52:5–11PubMedGoogle Scholar
  98. Rassnick S, Stinus L, Koob GF (1993) The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res 623:16–24PubMedGoogle Scholar
  99. Retson TA, Reyes BA, Van Bockstaele EJ (2015) Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of corticotropin releasing factor receptors. Prog Neuro-Psychopharmacol Biol Psychiatry 56:66–74Google Scholar
  100. Retson TA, Sterling RC, Van Bockstaele EJ (2016) Alcohol-induced dysregulation of stress-related circuitry: the search for novel targets and implications for interventions across the sexes. Prog Neuro-Psychopharmacol Biol Psychiatry 65:252–259Google Scholar
  101. Richardson HN, Lee SY, O’Dell LE, Koob GF, Rivier CL (2008) Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci 28:1641–1653PubMedPubMedCentralGoogle Scholar
  102. Riga D, Schmitz LJ, van der Harst JE, van Mourik Y, Hoogendijk WJ, Smit AB, De Vries TJ, Spijker S (2014) A sustained depressive state promotes a guanfacine reversible susceptibility to alcohol seeking in rats. Neuropsychopharmacology 39:1115–1124PubMedGoogle Scholar
  103. Rinaman L (2010) Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure. Brain Res 1350:18–34PubMedPubMedCentralGoogle Scholar
  104. Rinaman L (2011) Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am J Physiol Regul Integr Comp Physiol 300:R222–R235PubMedGoogle Scholar
  105. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267–287PubMedPubMedCentralGoogle Scholar
  106. Rodberg EM, den Hartog CR, Anderson RI, Becker HC, Moorman DE, Vazey EM (2017) Stress facilitates the development of cognitive dysfunction after chronic ethanol exposure. Alcohol Clin Exp Res 41:1574–1583PubMedPubMedCentralGoogle Scholar
  107. Roman CW, Derkach VA, Palmiter RD (2016) Genetically and functionally defined NTS to PBN brain circuits mediating anorexia. Nat Commun 7:11905PubMedPubMedCentralGoogle Scholar
  108. Ryabinin AE, Criado JR, Henriksen SJ, Bloom FE, Wilson MC (1997) Differential sensitivity of c-Fos expression in hippocampus and other brain regions to moderate and low doses of alcohol. Mol Psychiatry 2:32–43PubMedGoogle Scholar
  109. Sands SA, Morilak DA (1999) Expression of alpha1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus. Neuroscience 91:639–649PubMedGoogle Scholar
  110. Sara SJ (2015) Locus Coeruleus in time with the making of memories. Curr Opin Neurobiol 35:87–94PubMedGoogle Scholar
  111. Sawchenko PE, Swanson LW (1981) Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 214:685–687PubMedGoogle Scholar
  112. Sawchenko PE, Swanson LW (1982) The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res 257:275–325PubMedGoogle Scholar
  113. Sawchenko PE, Swanson LW, Grzanna R, Howe PR, Bloom SR, Polak JM (1985) Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241:138–153PubMedGoogle Scholar
  114. Sellers EM, Zilm DH, Degani NC (1977) Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. J Stud Alcohol 38:2096–2108PubMedGoogle Scholar
  115. Selvage D (2012) Roles of the locus coeruleus and adrenergic receptors in brain-mediated hypothalamic-pituitary-adrenal axis responses to intracerebroventricular alcohol. Alcohol Clin Exp Res 36:1084–1090PubMedGoogle Scholar
  116. Shefner SA, Tabakoff B (1985) Basal firing rate of rat locus coeruleus neurons affects sensitivity to ethanol. Alcohol 2:239–243PubMedGoogle Scholar
  117. Shields AD, Wang Q, Winder DG (2009) alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuroscience 163:339–351PubMedPubMedCentralGoogle Scholar
  118. Simpson TL, Saxon AJ, Meredith CW, Malte CA, McBride B, Ferguson LC, Gross CA, Hart KL, Raskind M (2009) A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcohol Clin Exp Res 33:255–263PubMedGoogle Scholar
  119. Simpson TL, Malte CA, Dietel B, Tell D, Pocock I, Lyons R, Varon D, Raskind M, Saxon AJ (2015) A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res 39:808–817PubMedPubMedCentralGoogle Scholar
  120. Skelly MJ, Weiner JL (2014) Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use. Brain Behav 4:468–483PubMedPubMedCentralGoogle Scholar
  121. Smith RJ, Aston-Jones G (2008) Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Brain Struct Funct 213:43–61PubMedPubMedCentralGoogle Scholar
  122. Sofuoglu M, Sewell RA (2009) Norepinephrine and stimulant addiction. Addict Biol 14:119–129PubMedGoogle Scholar
  123. Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A (2016) Propranolol for the treatment of anxiety disorders: systematic review and meta-analysis. J Psychopharmacol 30:128–139PubMedPubMedCentralGoogle Scholar
  124. Stornetta RL, Sevigny CP, Schreihofer AM, Rosin DL, Guyenet PG (2002) Vesicular glutamate transporter DNPI/VGLUT2 is expressed by both C1 adrenergic and nonaminergic presympathetic vasomotor neurons of the rat medulla. J Comp Neurol 444:207–220PubMedGoogle Scholar
  125. Strahlendorf HK, Strahlendorf JC (1983) Ethanol suppression of locus coeruleus neurons: relevancy to the fetal alcohol syndrome. Neurobehav Toxicol Teratol 5:221–224PubMedGoogle Scholar
  126. Swanson LW (1976) The locus coeruleus: a cytoarchitectonic, Golgi and immunohistochemical study in the albino rat. Brain Res 110:39–56PubMedGoogle Scholar
  127. Swanson LW, Hartman BK (1975) The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163:467–505PubMedGoogle Scholar
  128. Takeuchi T, Duszkiewicz AJ, Sonneborn A, Spooner PA, Yamasaki M, Watanabe M, Smith CC, Fernandez G, Deisseroth K, Greene RW, Morris RG (2016) Locus coeruleus and dopaminergic consolidation of everyday memory. Nature 537:357–362PubMedPubMedCentralGoogle Scholar
  129. Takigawa M, Mogenson GJ (1977) A study of inputs to antidromically identified neurons of the locus coeruleus. Brain Res 135:217–230PubMedGoogle Scholar
  130. Thiele TE, van Dijk G, Bernstein IL (1997) Ethanol-induced c-Fos expression in rat lines selected for low and high alcohol consumption. Brain Res 756:278–282PubMedGoogle Scholar
  131. Thiele TE, Cubero I, van Dijk G, Mediavilla C, Bernstein IL (2000) Ethanol-induced c-fos expression in catecholamine- and neuropeptide Y-producing neurons in rat brainstem. Alcohol Clin Exp Res 24:802–809PubMedGoogle Scholar
  132. Tjoumakaris SI, Rudoy C, Peoples J, Valentino RJ, Van Bockstaele EJ (2003) Cellular interactions between axon terminals containing endogenous opioid peptides or corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal pontine tegmentum. J Comp Neurol 466:445–456PubMedGoogle Scholar
  133. Valentino RJ, Foote SL (1988) Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats. J Neurosci 8:1016–1025PubMedGoogle Scholar
  134. Valentino RJ, Van Bockstaele E (2008) Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol 583:194–203PubMedPubMedCentralGoogle Scholar
  135. Van Bockstaele EJ, Bajic D, Proudfit H, Valentino RJ (2001) Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol Behav 73:273–283PubMedGoogle Scholar
  136. Ventura R, De Carolis D, Alcaro A, Puglisi-Allegra S (2006) Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex. Neuroreport 17:1813–1817PubMedGoogle Scholar
  137. Verbanck P, Seutin V, Dresse A, Scuvee J, Massotte L, Giesbers I, Kornreich C (1990) Electrophysiological effects of ethanol on monoaminergic neurons: an in vivo and in vitro study. Alcohol Clin Exp Res 14:728–735PubMedGoogle Scholar
  138. Verplaetse TL, Rasmussen DD, Froehlich JC, Czachowski CL (2012) Effects of prazosin, an alpha1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats. Alcohol Clin Exp Res 36:881–886PubMedGoogle Scholar
  139. Vilpoux C, Warnault V, Pierrefiche O, Daoust M, Naassila M (2009) Ethanol-sensitive brain regions in rat and mouse: a cartographic review, using immediate early gene expression. Alcohol Clin Exp Res 33:945–969PubMedGoogle Scholar
  140. Walker BM, Rasmussen DD, Raskind MA, Koob GF (2008) alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42:91–97PubMedPubMedCentralGoogle Scholar
  141. Wang ZJ, Rao ZR, Shi JW (1992) Tyrosine hydroxylase-, neurotensin-, or cholecystokinin-containing neurons in the nucleus tractus solitarii send projection fibers to the nucleus accumbens in the rat. Brain Res 578:347–350PubMedGoogle Scholar
  142. Waterhouse BD, Moises HC, Woodward DJ (1980) Noradrenergic modulation of somatosensory cortical neuronal responses to iontophoretically applied putative neurotransmitters. Exp Neurol 69:30–49PubMedGoogle Scholar
  143. Weinshenker D, Schroeder JP (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433–1451PubMedGoogle Scholar
  144. Weinshenker D, Rust NC, Miller NS, Palmiter RD (2000) Ethanol-associated behaviors of mice lacking norepinephrine. J Neurosci 20:3157–3164PubMedGoogle Scholar
  145. Wellman PJ (2000) Norepinephrine and the control of food intake. Nutrition 16:837–842PubMedGoogle Scholar
  146. Zaniewska M, Filip M, Przegalinski E (2015) The involvement of norepinephrine in behaviors related to psychostimulant addiction. Curr Neuropharmacol 13:407–418PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Elena M. Vazey
    • 1
    Email author
  • Carolina R. den Hartog
    • 1
  • David E. Moorman
    • 2
  1. 1.Department of Biology & Neuroscience and Behavior Graduate ProgramUniversity of Massachusetts AmherstAmherstUSA
  2. 2.Department of Psychological and Brain Sciences & Neuroscience and Behavior Graduate ProgramUniversity of Massachusetts AmherstAmherstUSA

Personalised recommendations